A phase 2 study of dasatinib, prednisone, and blinatumomab for older patients with philadelphia-chromosome (Ph) positive or Ph-like acute lymphoblastic leukemia (ALL) (with dasatinib sensitive fusions/ mutations) Meeting Abstract
| Authors: | Advani, A.; Moseley, A.; O'Dwyer, K.; Wood, B.; Park, J. H.; Wieduwilt, M.; Jeyakumar, D.; Yaghmour, G.; Atallah, E. L.; Gerds, A. T.; O'Brien, S. M.; Liesveld, J. L.; Othus, M.; Litzow, M. R.; Stone, R. M.; Sharon, E.; Erba, H. P. |
| Abstract Title: | A phase 2 study of dasatinib, prednisone, and blinatumomab for older patients with philadelphia-chromosome (Ph) positive or Ph-like acute lymphoblastic leukemia (ALL) (with dasatinib sensitive fusions/ mutations) |
| Meeting Title: | 63nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736413905214 |
| DOI: | 10.1182/blood-2021-145529 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3397 -- Hybrid meeting, also took place online -- Source: Wos |
